Endogenous mediators that inhibit the leukocyte- endothelium interaction

By Perretti M.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 418-425

Elsevier

Access to resources Recommend Favorite

Functional evidence that K + is the non-nitric oxide, non-prostanoid endothelium-derived relaxing factor in rat femoral arteries

By Savage D.   Perkins J.   Hong Lim C.   Bund S.J.  

General Pharmacology, Vol. 40, Iss. 1, 2003-01 ,pp. : 23-28

Elsevier

Access to resources Recommend Favorite

Therapeutic Strategies in Autoimmune Diseases by Interfering with Leukocyte Endothelium Interaction

By  

Current Pharmaceutical Design, Vol. 12, Iss. 29, 2006-10 ,pp. : 3799-3806

Bentham Science Publishers

Access to resources Recommend Favorite

Idoxifene causes endothelium-dependent, nitric oxide-mediated vasorelaxation in male rats

By Christopher T.A.   Lopez B.L.   Stillwagon J.C.   Gao F.   Gao E.   Ma X.-L.   Ohlstein E.H.   Yue T.-L.  

European Journal of Pharmacology, Vol. 446, Iss. 1, 2002-06 ,pp. : 139-143

Elsevier

Access to resources Recommend Favorite

Dioclein, a new nitric oxide- and endothelium-dependent vasodilator flavonoid

By Lemos V.S.   Freitas M.R.   Muller B.   Lino Y.D.   Queiroga C.E.G.   Cortes S.F.  

European Journal of Pharmacology, Vol. 386, Iss. 1, 1999-12 ,pp. : 41-46

Elsevier

Access to resources Recommend Favorite